Kyle A. Emmitte

3.2k total citations
68 papers, 2.2k citations indexed

About

Kyle A. Emmitte is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Kyle A. Emmitte has authored 68 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 44 papers in Cellular and Molecular Neuroscience and 11 papers in Organic Chemistry. Recurrent topics in Kyle A. Emmitte's work include Neuroscience and Neuropharmacology Research (41 papers), Receptor Mechanisms and Signaling (25 papers) and Pharmacological Receptor Mechanisms and Effects (10 papers). Kyle A. Emmitte is often cited by papers focused on Neuroscience and Neuropharmacology Research (41 papers), Receptor Mechanisms and Signaling (25 papers) and Pharmacological Receptor Mechanisms and Effects (10 papers). Kyle A. Emmitte collaborates with scholars based in United States, Australia and United Kingdom. Kyle A. Emmitte's co-authors include Craig W. Lindsley, Michael T. Crimmins, P. Jeffrey Conn, Colleen M. Niswender, Corey R. Hopkins, Alice L. Rodriguez, Andrew S. Felts, Karen J. Gregory, J. Scott Daniels and Carrie K. Jones and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Kyle A. Emmitte

65 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle A. Emmitte United States 29 1.4k 1.0k 550 185 166 68 2.2k
Richard W. Ransom United States 29 2.4k 1.7× 1.9k 1.9× 660 1.2× 242 1.3× 82 0.5× 73 4.4k
Youseung Shin United States 23 1.2k 0.9× 188 0.2× 666 1.2× 391 2.1× 156 0.9× 41 2.8k
Corey R. Hopkins United States 36 2.6k 1.9× 1.6k 1.6× 515 0.9× 163 0.9× 112 0.7× 145 4.1k
Stephen R. Fletcher United States 20 941 0.7× 323 0.3× 640 1.2× 182 1.0× 45 0.3× 38 1.8k
Raymond S.L. Chang United States 31 2.7k 2.0× 1.6k 1.6× 1.6k 3.0× 277 1.5× 47 0.3× 114 4.7k
Frédéric Bihel France 27 817 0.6× 393 0.4× 643 1.2× 112 0.6× 97 0.6× 85 1.9k
Anna Katrin Szardenings United States 19 1.0k 0.7× 308 0.3× 527 1.0× 185 1.0× 81 0.5× 27 2.7k
Lawrence P. Wennogle United States 30 1.7k 1.2× 761 0.8× 202 0.4× 202 1.1× 165 1.0× 69 2.6k
Wha Bin Im United States 28 1.4k 1.0× 771 0.8× 435 0.8× 165 0.9× 89 0.5× 85 2.3k
Scott J. Pollack United States 22 1.4k 1.0× 351 0.3× 323 0.6× 158 0.9× 314 1.9× 38 2.4k

Countries citing papers authored by Kyle A. Emmitte

Since Specialization
Citations

This map shows the geographic impact of Kyle A. Emmitte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle A. Emmitte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle A. Emmitte more than expected).

Fields of papers citing papers by Kyle A. Emmitte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle A. Emmitte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle A. Emmitte. The network helps show where Kyle A. Emmitte may publish in the future.

Co-authorship network of co-authors of Kyle A. Emmitte

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle A. Emmitte. A scholar is included among the top collaborators of Kyle A. Emmitte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle A. Emmitte. Kyle A. Emmitte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abramyan, Tigran M., Dustin E. Bosch, Kyle A. Emmitte, et al.. (2025). Developing inhibitors of the guanosine triphosphate hydrolysis accelerating activity of Regulator of G protein Signaling-14. Journal of Biological Chemistry. 301(10). 110611–110611.
4.
McKay, Tina B., Kyle A. Emmitte, Carrie German, & Dimitrios Karamichos. (2023). Quercetin and Related Analogs as Therapeutics to Promote Tissue Repair. Bioengineering. 10(10). 1127–1127. 18 indexed citations
5.
Du, Yu, et al.. (2022). Structure–activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels. Bioorganic & Medicinal Chemistry Letters. 76. 129013–129013. 7 indexed citations
6.
Felts, Andrew S., Alice L. Rodriguez, Ryan D. Morrison, et al.. (2018). Discovery of 4-alkoxy-6-methylpicolinamide negative allosteric modulators of metabotropic glutamate receptor subtype 5. Bioorganic & Medicinal Chemistry Letters. 29(1). 47–50. 4 indexed citations
7.
Walker, Adam G., Douglas J. Sheffler, Andrew Lewis, et al.. (2017). Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation. Neuropsychopharmacology. 42(13). 2553–2566. 16 indexed citations
8.
Byers, Frank W., et al.. (2016). Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity. Drug Metabolism and Disposition. 44(8). 1296–1303. 18 indexed citations
9.
Nickols, Hilary Highfield, Karen J. Gregory, Shaun R. Stauffer, et al.. (2015). VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy. Journal of Pharmacology and Experimental Therapeutics. 356(1). 123–136. 28 indexed citations
10.
Rook, Jerri M., Mohammed Noor Tantawy, M. Sib Ansari, et al.. (2014). Relationship between In Vivo Receptor Occupancy and Efficacy of Metabotropic Glutamate Receptor Subtype 5 Allosteric Modulators with Different In Vitro Binding Profiles. Neuropsychopharmacology. 40(3). 755–765. 33 indexed citations
11.
Cho, Hyekyung P., Darren W. Engers, Daryl F. Venable, et al.. (2014). A Novel Class of Succinimide-Derived Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Provides Insight into a Disconnect in Activity between the Rat and Human Receptors. ACS Chemical Neuroscience. 5(7). 597–610. 47 indexed citations
12.
Felts, Andrew S., Alice L. Rodriguez, Ryan D. Morrison, et al.. (2013). Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety. Bioorganic & Medicinal Chemistry Letters. 23(21). 5779–5785. 27 indexed citations
13.
Manka, Jason, Alice L. Rodriguez, Ryan D. Morrison, et al.. (2013). Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1. Bioorganic & Medicinal Chemistry Letters. 23(18). 5091–5096. 9 indexed citations
14.
Felts, Andrew S., Alice L. Rodriguez, Daryl F. Venable, et al.. (2013). Substituted 1-Phenyl-3-(pyridin-2-yl)urea Negative Allosteric Modulators of mGlu5: Discovery of a New Tool Compound VU0463841 with Activity in Rat Models of Cocaine Addiction. ACS Chemical Neuroscience. 4(8). 1217–1228. 14 indexed citations
15.
Lovell, Kimberly M., Andrew S. Felts, Alice L. Rodriguez, et al.. (2013). N-Acyl-N′-arylpiperazines as negative allosteric modulators of mGlu1: Identification of VU0469650, a potent and selective tool compound with CNS exposure in rats. Bioorganic & Medicinal Chemistry Letters. 23(13). 3713–3718. 13 indexed citations
16.
Wenthur, Cody J., Ryan D. Morrison, Andrew S. Felts, et al.. (2013). Discovery of (R)-(2-Fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-Hydroxypiperidin-1-yl)methanone (ML337), An mGlu3 Selective and CNS Penetrant Negative Allosteric Modulator (NAM). Journal of Medicinal Chemistry. 56(12). 5208–5212. 47 indexed citations
17.
Lindsley, Craig W., Usha N. Menon, Satyawan Jadhav, et al.. (2011). (3-Cyano-5-fluorophenyl)biaryl Negative Allosteric Modulators of mGlu5: Discovery of a New Tool Compound with Activity in the OSS Mouse Model of Addiction. ACS Chemical Neuroscience. 2(8). 471–482. 18 indexed citations
18.
Melancon, Bruce J., Corey R. Hopkins, Michael R. Wood, et al.. (2011). Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery. Journal of Medicinal Chemistry. 55(4). 1445–1464. 188 indexed citations
19.
Thériault, Jimmy R., Andrew S. Felts, José R. Perez, et al.. (2011). Discovery of a new molecular probe ML228: An activator of the hypoxia inducible factor (HIF) pathway. Bioorganic & Medicinal Chemistry Letters. 22(1). 76–81. 24 indexed citations
20.
Sabbatini, Peter, Jason L. Rowand, Arthur Groy, et al.. (2009). Antitumor Activity of GSK1904529A, a Small-molecule Inhibitor of the Insulin-like Growth Factor-I Receptor Tyrosine Kinase. Clinical Cancer Research. 15(9). 3058–3067. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026